SA

Sunil Anantrao Kadu

Active Director Director DIN 09822919
DIN 09822919 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value •••• Premium profile

About Sunil Anantrao Kadu

Data last updated:

Sunil Anantrao Kadu is a Director at Pride Drugs And Pharma Private Limited (since 2022). The company operates in Pharma. Pride Drugs And Pharma Private Limited reported revenue of ₹66.89 Cr (FY 2025).

DIN 09822919
Primary Designation Director
Industry Pharma
First Appointment 14 Dec 2022
Oldest Company Age 21 yrs
Largest company Pride Drugs And Pharma Private Limited · ₹66.89 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Dec 20222005₹66.89 Cr (FY 2025)Active

Board colleagues of Sunil Anantrao Kadu

Directorship timeline

Open interactive timeline →
Pride Drugs And Pharma Private Limited
Premium access

Shareholding and investment profile for Sunil Anantrao Kadu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Anantrao Kadu

Sunil Anantrao Kadu currently holds 1 directorship: Pride Drugs And Pharma Private Limited (Director, since 14 Dec 2022, revenue ₹66.89 Cr (FY 2025)).

Sunil Anantrao Kadu was first appointed on 14 Dec 2022 as Director at Pride Drugs And Pharma Private Limited.

The current boards of Sunil Anantrao Kadu's companies include Jigar Vyas (Pride Drugs And Pharma Private Limited), Manojkumar Shah Jashwantlal (Pride Drugs And Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available